Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -362.95% is 35% above its 3-year average of -560.37%, near the high end of its 3-year range (-5133.85%–-285.37%).
0.81% below its 12-month average of -360.04%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -388.89%.
OPERATING MARGIN
-362.95%
OPERATING MARGIN AVG TTM
-360.04%
OPERATING MARGIN AVG 3Y
-516.88%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.81%
CURRENT VS 3Y AVG
+29.78%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$5.95B
Operating Margin
17.61%
TTM Avg
2.04%
3Y Avg
3.68%
5Y Avg
13.44%
Market Cap
$5.87B
Operating Margin
-153.08%
TTM Avg
-197.00%
3Y Avg
-9782.25%
5Y Avg
-6521.50%
Market Cap
$5.76B
Operating Margin
11.92%
TTM Avg
0.31%
3Y Avg
-1.06%
5Y Avg
-68.44%
Market Cap
$5.71B
Operating Margin
-4722.13%
TTM Avg
-7394.69%
3Y Avg
-15105.91%
5Y Avg
-12109.07%
Market Cap
$6.33B
Operating Margin
-101.19%
TTM Avg
-152.62%
3Y Avg
-325.31%
5Y Avg
-1115.52%
Market Cap
$5.54B
Operating Margin
0.53%
TTM Avg
-2.93%
3Y Avg
-2.93%
5Y Avg
-2.93%
Market Cap
$6.51B
Operating Margin
19.43%
TTM Avg
24.98%
3Y Avg
20.49%
5Y Avg
11.07%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRAIL Inc. (GRAL) | $5.94B | -362.95% | -360.04% | -516.88% | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 17.61% | 2.04% | 3.68% | 13.44% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.87B | -153.08% | -197.00% | -9782.25% | -6521.50% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.76B | 11.92% | 0.31% | -1.06% | -68.44% |
| CG Oncology Inc. (CGON)vs › | $5.71B | -4722.13% | -7394.69% | -15105.91% | -12109.07% |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.33B | -101.19% | -152.62% | -325.31% | -1115.52% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.54B | 0.53% | -2.93% | -2.93% | -2.93% |
| RadNet, Inc. (RDNT)vs › | $5.52B | 4.00% | 5.08% | 4.88% | 4.85% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 19.43% | 24.98% | 20.49% | 11.07% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.52B | 12.93% | 11.47% | 6.80% | 6.51% |
Gross Margin
-42.5%
Operating Margin
-362.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -388.89% |
| 2026-03-31 | -332.88% |
| 2025-12-31 | -285.37% |
| 2025-09-30 | -346.17% |
| 2025-06-30 | -446.92% |
| 2025-03-31 | -482.48% |
| 2024-12-31 | -357.99% |
| 2024-09-30 | -640.47% |
| 2024-06-30 | -5133.85% |
| 2024-03-31 | -851.10% |
| 2023-12-31 | -641.67% |
| 2023-09-30 | -4403.01% |
| 2023-06-30 | -911.78% |
| 2023-04-02 | -1038.70% |
